Published in Contrib Nephrol on January 01, 1989
Iron, anaemia, and inflammatory bowel diseases. Gut (2004) 2.03
Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ (1992) 1.50
Poor response to erythropoietin. BMJ (1995) 1.43
Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm. BMJ (1990) 1.16
Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes. BMC Nephrol (2013) 0.81
The use of erythropoietin in renal failure. Postgrad Med J (1991) 0.80
Exercise aggravates cardiovascular risks and mortality in rats with disrupted nitric oxide pathway and treated with recombinant human erythropoietin. Eur J Appl Physiol (2011) 0.77
Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study. BMC Nephrol (2005) 0.75
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med (1998) 11.58
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med (1987) 5.57
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet (1986) 4.04
Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A (1985) 3.28
Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med (1976) 3.18
Isolation, characterization, and comparison of recombinant DNAs derived from genomes of human hepatitis B virus and woodchuck hepatitis virus. Proc Natl Acad Sci U S A (1980) 3.04
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med (1989) 2.43
Ferrokinetics in man. Medicine (Baltimore) (1970) 2.08
Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 2.06
Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med (1989) 1.90
Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer (2001) 1.72
Stored placental blood for unrelated bone marrow reconstitution. Blood (1993) 1.72
Anemia of end-stage renal disease (ESRD). Kidney Int (1985) 1.63
Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am J Kidney Dis (1990) 1.57
Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin. J Clin Invest (1978) 1.53
The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation. Blood (1968) 1.48
Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 1.46
Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest (1987) 1.45
The anemia of chronic disorders: studies of marrow regulation and iron metabolism. Blood (1975) 1.40
Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant (2001) 1.40
The kidney and erythropoiesis. Am J Med (1968) 1.39
The pathogenesis of myeloproliferative syndromes. Br J Haematol (1978) 1.39
Comparative analysis of hematopoietic growth factors released by stromal cells from normal donors or transplanted patients. Blood (1990) 1.38
Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol (1989) 1.37
Human ribosomal RNA gene spacer sequences are found interspersed elsewhere in the genome. Gene (1981) 1.36
Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells (1994) 1.35
Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. N Engl J Med (1987) 1.32
Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. J Immunol (1987) 1.30
Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation. J Clin Invest (1988) 1.27
Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood (1981) 1.26
Erythrocytosis associated with hemoglobin Rainier: oxygen equilibria and marrow regulation. J Clin Invest (1969) 1.23
Characteristics of murine megakaryocytic colonies in vitro. Blood (1979) 1.22
Primary structure of human prethrombin 2 and alpha-thrombin. J Biol Chem (1977) 1.21
Nucleotide sequences from the rabbit beta globin gene inserted into Escherichia coli plasmids. Science (1977) 1.21
Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods (1987) 1.21
Characterization and biological effects of recombinant human erythropoietin. Immunobiology (1986) 1.20
Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proc Natl Acad Sci U S A (1991) 1.19
Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide. Proc Natl Acad Sci U S A (1988) 1.13
Human prothrombin activation. J Biol Chem (1975) 1.12
Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proc Natl Acad Sci U S A (1991) 1.12
Recombinant human erythropoietin: implications for nephrology. Am J Kidney Dis (1988) 1.12
Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow. J Cell Physiol Suppl (1982) 1.11
The influence of thyroid hormones on in vitro erythropoiesis. Mediation by a receptor with beta adrenergic properties. J Clin Invest (1977) 1.10
Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth. J Cell Physiol (1984) 1.07
Conversion of a Golgi apparatus sialyltransferase to a secretory protein by replacement of the NH2-terminal signal anchor with a signal peptide. J Biol Chem (1989) 1.06
Steroids and hematopoiesis. I. The effect of steroids on in vitro erythroid colony growth: structure/activity relationships. J Cell Physiol (1976) 1.05
Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood (1992) 1.03
Human erythroid colony formation in vitro: evidence for clonal origin. J Cell Physiol (1976) 1.03
The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo. J Clin Invest (1984) 1.02
Hemoglobin function, oxygen affinity, and erythropoietin. Annu Rev Physiol (1975) 1.01
Characterization of recombinant monkey and human erythropoietin. Prog Clin Biol Res (1985) 1.01
Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry (1978) 1.01
Guidelines for recombinant human erythropoietin therapy. Am J Kidney Dis (1989) 1.01
Isolation, characterization, and expression of a cDNA encoding N-acetylglucosaminyltransferase V. J Biol Chem (1993) 1.00
Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation. J Clin Invest (1977) 1.00
Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol (1986) 0.99
Pancytopenia as a clonal disorder of a multipotent hematopoietic stem cell. J Clin Invest (1984) 0.99
The safety of epoetin-alpha: results of clinical trials in the United States. Contrib Nephrol (1991) 0.99
Polycythemia vera. Increased expression of normal committed granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine. J Clin Invest (1979) 0.98
Feline glucose-6-phosphate dehydrogenase cellular mosaicism. Application to the study of retrovirus-induced pure red cell aplasia. J Clin Invest (1985) 0.97
Modulation of in vitro erythropoiesis: enhancement of erythroid colony growth by cyclic nucleotides. Cell Tissue Kinet (1977) 0.97
Polycythemia: mechanisms and management. Ann Intern Med (1981) 0.97
Detection of mutant hemoglobins with altered affinity for oxygen. A simplified technique. Ann Intern Med (1976) 0.95
Hemoglobin olympia ( 20 valine leads to methionine): an electrophoretically silent variant associated with high oxygen affinity and erythrocytosis. J Clin Invest (1973) 0.94
Activation of hemoglobin C synthesis in sheep marrow culture. Science (1973) 0.93
Erythropoietin excretion in normal man. Blood (1966) 0.93
Erythropoietin: gene cloning, protein structure, and biological properties. Cold Spring Harb Symp Quant Biol (1986) 0.92
Treatment of aplastic anemia by bone marrow transplantation in identical twins. Blood (1980) 0.92
Polycythemia vera. Further in vitro studies of hematopoietic regulation. J Clin Invest (1980) 0.92
Megakaryocytopoiesis in the mouse: response to varying platelet demand. J Cell Physiol (1981) 0.92
Modulation of in vitro erythropoiesis. Studies with euthyroid and hypothyroid dogs. J Clin Invest (1979) 0.92
Familial polycythemia. Semin Hematol (1975) 0.92
Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome. Blood (1980) 0.91
Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro. J Cell Physiol (1991) 0.91
Steroids and hematopoiesis. II. The effect of steroids on in vitro erythroid colony growth: evidence for different target cells for different classes of steroids. J Cell Physiol (1976) 0.91
Perioperative recombinant human erythropoietin. Surgery (1989) 0.90
Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. Stem Cells Dev (2004) 0.90
Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Kidney Int (2000) 0.90
Hematopoiesis in the grey collie dog: studies of the regulation of erythropoiesis. J Clin Invest (1974) 0.90
Steroids and hematopoiesis. III. The response of granulocytic and erythroid colony-forming cells to steroids of different classes. Blood (1976) 0.90
Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia. J Clin Invest (1985) 0.90
Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization. Proc Natl Acad Sci U S A (1986) 0.90
Suppression of cutaneous perception by magnetic pulse stimulation of the human brain. Electroencephalogr Clin Neurophysiol (1992) 0.89